Press-release for stocks for TMO

Prices are updated after-hours

FDA, NIH, and 15 private organizations join forces to increase effective gene therapies for rare diseases
Published: 2021-10-27 (Crawled : 20:00) - fda.gov
TMO | News | $543.03 0.28% 300K

| -12.95% | O: 0.44% H: 2.01% C: 0.82%
TAK | News | $13.255 0.72% 200K

| -4.85% | O: 2.03% H: 3.33% C: 0.07%
RGNX | $15.925 -1.15% 120K

| -51.65% | O: 0.91% H: 2.93% C: 2.79%
BIIB | $191.45 0.49% 310K

| -24.93% | O: 0.19% H: 2.32% C: 1.7%
disease fda gene therapies therapy gene therapy rare

79%

21%

AGBA | News | $1.22 205.0% 86M

EGOX | $0.0606 68.33% 250M

NVFY | $3.45 63.51% 20M

ZCMD | $1.98 36.55% 27M

CHRO | $1.66 35.51% 70K

INDO | $5.43 33.09% 10M

PAPL | $2.07 26.22% 550K

RWOD | $10.08 26.05% 5.6M

AULT | $0.304 25.57% 47M

HUSA 4 | $2.07 23.95% 2.1M

Save your searches and get alerts when important news are released.